跳至主要内容
临床试验/NCT04275947
NCT04275947Unknown不适用

The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp

Chinese Alliance Against Lung Cancer1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2020年2月14日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
450
试验地点
1
主要终点
Accuracy of nCapp COVID-19 risk diagnostic model

研究概览

简要总结

This study evaluates a brand-new cell phone-based auto-diagnosis system, which is based on the clinical guidelines, clinical experience, and statistic training model. We will achieve secure and 1st hand data from physicians in Wuhan, which including 150 cases in the training cohort and 300 cases in the validation cohort.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •High risk of COVID-19
  • •RT-PCR test result of SAR2-CoV-19

排除标准

  • •Not available for RT-PCR test result of SAR2-CoV-19

结局指标

主要结局

Accuracy of nCapp COVID-19 risk diagnostic model

时间窗: 1 day

Sensitivity, specificity and area under the ROC curve of nCapp model

次要结局

未报告次要终点

研究者

发起方
Chinese Alliance Against Lung Cancer
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bai Chunxue

Chair

Chinese Alliance Against Lung Cancer

研究点 (1)

Loading locations...

相似试验

The COVID-19 Mobile Health Study (CMHS) | 临床试验